Aravive, Inc.·4

Mar 4, 4:49 PM ET

McIntyre Gail Frances 4

4 · Aravive, Inc. · Filed Mar 4, 2019

Insider Transaction Report

Form 4
Period: 2019-02-28
McIntyre Gail Frances
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2019-02-28+53,00053,000 total
    Exercise: $5.83From: 2019-03-28Exp: 2029-02-27Common Stock (53,000 underlying)
Footnotes (1)
  • [F1]These options vest pro rata on a monthly basis over 48 months.

Documents

2 files